We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $754M
1-Year Est. Return 60.05%
This Fund
S&P 500
This Quarter Est. Return
+3.93%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$548M
AUM Growth
+$7.66M
Cap. Flow
-$12M
Cap. Flow %
-2.19%
Top 10 Hldgs %
32.65%
Holding
154
New
7
Increased
23
Reduced
102
Closed
2

Top Sells

Rank Stock Value
1
EXC icon
Exelon
EXC
+$4.98M
2
STE icon
Steris
STE
+$4.1M
3
FCX icon
Freeport-McMoran
FCX
+$2.26M
4
ADI icon
Analog Devices
ADI
+$2.16M
5
JNJ icon
Johnson & Johnson
JNJ
+$1.91M

Sector Composition

Rank Sector Weight
1 Healthcare 24.56%
2 Industrials 19.03%
3 Technology 17.84%
4 Energy 9.49%
5 Utilities 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEX icon
76
Terex
TEX
$7.44B
$2M 0.36%
+48,600
New +$1.98M
PBR icon
77
Petrobras
PBR
$120B
$1.98M 0.36%
135,050
-5,000
-4% -$72.8K
STJ
78
DELISTED
St Jude Medical
STJ
$1.96M 0.36%
28,349
-900
-3% -$58.3K
CCC
79
DELISTED
Calgon Carbon Corp
CCC
$1.9M 0.35%
85,100
-5,700
-6% -$121K
CGW icon
80
Invesco S&P Global Water Index ETF
CGW
$1.05B
$1.9M 0.35%
62,970
-4,750
-7% -$139K
VALE icon
81
Vale
VALE
$62B
$1.82M 0.33%
137,575
-3,700
-3% -$49.9K
IAF
82
abrdn Australia Equity Fund
IAF
$122M
$1.71M 0.31%
62,924
-7,233
-10% -$196K
ZBH icon
83
Zimmer Biomet
ZBH
$18.6B
$1.7M 0.31%
16,891
-1,081
-6% -$105K
AEGN
84
DELISTED
Aegion Corp
AEGN
$1.68M 0.31%
72,350
-6,100
-8% -$145K
TRP icon
85
TC Energy
TRP
$70.6B
$1.65M 0.3%
34,520
+100
+0.3% +$4.67K
COV
86
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$1.57M 0.29%
17,450
-1,700
-9% -$127K
ESBK
87
DELISTED
Elmira Savings Bank Elmira NY
ESBK
$1.45M 0.27%
62,323
-1,058
-2% -$23.5K
ELP
88
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
$1.42M 0.26%
232,000
-2,250
-1% -$13.3K
ALTR
89
DELISTED
Altera Corp
ALTR
$1.42M 0.26%
+40,800
New +$1.38M
LGTY
90
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$1.39M 0.25%
141,073
-6,900
-5% -$66.6K
FXI icon
91
iShares China Large-Cap ETF
FXI
$4.31B
$1.39M 0.25%
37,430
-4,300
-10% -$156K
SYT
92
DELISTED
Syngenta Ag
SYT
$1.39M 0.25%
18,520
-624
-3% -$48K
EME icon
93
Emcor
EME
$30.2B
$1.35M 0.25%
30,300
-300
-1% -$13.6K
SYK icon
94
Stryker
SYK
$134B
$1.35M 0.25%
15,970
-20
-0.1% -$1.63K
BAX icon
95
Baxter International
BAX
$12.8B
$1.34M 0.24%
34,081
-1,194
-3% -$47.8K
XRX icon
96
Xerox
XRX
$360M
$1.34M 0.24%
40,796
+114
+0.3% +$3.62K
BRXX
97
DELISTED
EGSHARES BRAZIL INFRASTURE ETF
BRXX
$1.32M 0.24%
77,895
-15,220
-16% -$254K
HDNG
98
DELISTED
Hardinge Inc
HDNG
$1.26M 0.23%
99,506
+37,500
+60% +$482K
NWE icon
99
NorthWestern Energy
NWE
$4.44B
$1.21M 0.22%
23,250
-200
-0.9% -$9.61K
GOOG icon
100
Alphabet (Google) Class C
GOOG
$4.07T
$1.2M 0.22%
41,253
-41,536
-50% -$1.13M

Similar funds

John G. Ullman & Associates's Q2 2014 Portfolio in Review

As of Q2 2014, John G. Ullman & Associates held 154 positions worth $548M, up 1.4% from $540M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

John G. Ullman & Associates's Q2 2014 filing shows 7 new, 23 increased, 102 reduced and 2 closed positions. Its largest new stake was State Street SPDR S&P Biotech ETF: 47,646 shares worth $2.45M. The largest sale was Exelon, an estimated $4.98M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 25% a quarter earlier, followed by Industrials and Technology.

  • John G. Ullman & Associates's largest Q2 2014 buy was State Street SPDR S&P Biotech ETF: 47,646 shares worth $2.45M.
  • John G. Ullman & Associates added most to Otter Tail in Q2 2014, an estimated $3.75M increase.
  • John G. Ullman & Associates's biggest Q2 2014 reduction was Exelon, cutting an estimated $4.98M.
  • John G. Ullman & Associates fully exited Halliburton in Q2 2014, selling an estimated $707K.
  • John G. Ullman & Associates's ten largest holdings make up 33% of its $548M portfolio in Q2 2014.
  • John G. Ullman & Associates opened 7 new positions and closed 2 in Q2 2014.
  • John G. Ullman & Associates's portfolio value rose 1.4% quarter-over-quarter to $548M.

Based on John G. Ullman & Associates's 13F filing for Q2 2014, filed 18 Jul 2014.